Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05153278 · ClinicalTrials.gov registry record
IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department
A clinical trial, sponsored by Texas Tech University Health Sciences Center, El Paso.
- Completed
- Registry status
- 130
- Enrollment target
NCT05153278: Completed study, sponsored by Texas Tech University Health Sciences Center, El Paso.
NCT05153278 is a clinical trial that has completed, run by Texas Tech University Health Sciences Center, El Paso. The registered enrollment target is 130 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05153278 has completed, sponsored by Texas Tech University Health Sciences Center, El Paso.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
Study Summary
The investigators will retrospectively collect data of patients infused at UMC's emergency department (ED) with long acting irons (ferric carboxymaltose, iron dextran, iron sucrose, etc.), in addition, patients infused with blood products, with intent to treat iron deficiency anemia (IDA). Patient records reviewed will be from patients who were infused at UMC ED from January 2013 to June 2018. Primary aim of analysis will be to investigate superiority between interventions implemented for treating IDA. In addition, the investigators will utilize data to characterize patients who used ED services as an avenue to receive treatment for IDA. Further, the investigators will conduct cost analysis between different IDA directed treatments administered in the ED at UMC.
Primary Outcome
Change in serum hemoglobin over time
Interventions
- DRUG Intravenous drug
- BIOLOGICAL Packed red blood cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2018-10-26 |
| Est. Completion | 2020-08-26 |
What the finished NCT05153278 record still lists
NCT05153278 is an observational study that tracks outcomes without assigning an intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Intravenous drug is the first listed.
NCT05153278 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05153278 about?
NCT05153278 is a clinical study titled "IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department". The investigators will retrospectively collect data of patients infused at UMC's emergency department (ED) with long acting irons (ferric carboxymaltose, iron dextran, iron sucrose, etc.), in addition, patients infused with blood products, with intent to treat iron deficiency anemia (IDA). Patient r...
What is the current status of trial NCT05153278?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2018-10-26. Estimated completion is 2020-08-26.
What interventions are being tested in trial NCT05153278?
The interventions under investigation include: Intravenous drug (DRUG), Packed red blood cells (BIOLOGICAL).
Who is sponsoring clinical trial NCT05153278?
This trial is sponsored by Texas Tech University Health Sciences Center, El Paso, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI